Literature DB >> 22201794

RUNX1 and RUNX1-ETO: roles in hematopoiesis and leukemogenesis.

Kentson Lam1, Dong-Er Zhang.   

Abstract

RUNX1 is a transcription factor that regulates critical processes in many aspects of hematopoiesis. RUNX1 is also integral in defining the definitive hematopoietic stem cell. In addition, many hematological diseases like myelodysplastic syndrome and myeloproliferative neoplasms have been associated with mutations in RUNX1. Located on chromosomal 21, the RUNX1 gene is involved in many forms of chromosomal translocations in leukemia. t(8;21) is one of the most common chromosomal translocations found in acute myeloid leukemia (AML), where it results in a fusion protein between RUNX1 and ETO. The RUNX1-ETO fusion protein is found in approximately 12% of all AML patients. In this review, we detail the structural features, functions, and models used to study both RUNX1 and RUNX1-ETO in hematopoiesis over the past two decades.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22201794      PMCID: PMC3433167          DOI: 10.2741/3977

Source DB:  PubMed          Journal:  Front Biosci (Landmark Ed)        ISSN: 2768-6698


  180 in total

1.  The mouse Runx1 +23 hematopoietic stem cell enhancer confers hematopoietic specificity to both Runx1 promoters.

Authors:  Thomas Bee; Emma L K Ashley; Sorrel R B Bickley; Andrew Jarratt; Pik-Shan Li; Jackie Sloane-Stanley; Berthold Göttgens; Marella F T R de Bruijn
Journal:  Blood       Date:  2009-03-25       Impact factor: 22.113

2.  Transcriptional regulation of the transforming growth factor-beta -inducible mouse germ line Ig alpha constant region gene by functional cooperation of Smad, CREB, and AML family members.

Authors:  Y Zhang; R Derynck
Journal:  J Biol Chem       Date:  2000-06-02       Impact factor: 5.157

3.  Six distinct nuclear factors interact with the 75-base-pair repeat of the Moloney murine leukemia virus enhancer.

Authors:  N A Speck; D Baltimore
Journal:  Mol Cell Biol       Date:  1987-03       Impact factor: 4.272

Review 4.  The Runt domain identifies a new family of heteromeric transcriptional regulators.

Authors:  H Kagoshima; K Shigesada; M Satake; Y Ito; H Miyoshi; M Ohki; M Pepling; P Gergen
Journal:  Trends Genet       Date:  1993-10       Impact factor: 11.639

5.  Identification of a region which directs the monocytic activity of the colony-stimulating factor 1 (macrophage colony-stimulating factor) receptor promoter and binds PEBP2/CBF (AML1).

Authors:  D E Zhang; K Fujioka; C J Hetherington; L H Shapiro; H M Chen; A T Look; D G Tenen
Journal:  Mol Cell Biol       Date:  1994-12       Impact factor: 4.272

6.  ETO, fusion partner in t(8;21) acute myeloid leukemia, represses transcription by interaction with the human N-CoR/mSin3/HDAC1 complex.

Authors:  J Wang; T Hoshino; R L Redner; S Kajigaya; J M Liu
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

7.  Differentiation-dependent interactions between RUNX-1 and FLI-1 during megakaryocyte development.

Authors:  Hui Huang; Ming Yu; Thomas E Akie; Tyler B Moran; Andrew J Woo; Nathan Tu; Zachary Waldon; Yin Yin Lin; Hanno Steen; Alan B Cantor
Journal:  Mol Cell Biol       Date:  2009-05-26       Impact factor: 4.272

Review 8.  The 8;21 translocation in leukemogenesis.

Authors:  Luke F Peterson; Dong-Er Zhang
Journal:  Oncogene       Date:  2004-05-24       Impact factor: 9.867

9.  Cbfa2 is required for the formation of intra-aortic hematopoietic clusters.

Authors:  T North; T L Gu; T Stacy; Q Wang; L Howard; M Binder; M Marín-Padilla; N A Speck
Journal:  Development       Date:  1999-06       Impact factor: 6.868

10.  Runx-CBFbeta complexes control expression of the transcription factor Foxp3 in regulatory T cells.

Authors:  Dipayan Rudra; Takeshi Egawa; Mark M W Chong; Piper Treuting; Dan R Littman; Alexander Y Rudensky
Journal:  Nat Immunol       Date:  2009-09-20       Impact factor: 25.606

View more
  74 in total

1.  Response: the role of RUNX1 isoforms in hematopoietic commitment of human pluripotent stem cells.

Authors:  Dan Ran; Kentson Lam; Wei-Jong Shia; Miao-Chia Lo; Jun-Bao Fan; David A Knorr; Patrick I Ferrell; Zhaohui Ye; Ming Yan; Linzhao Cheng; Dan S Kaufman; Dong-Er Zhang
Journal:  Blood       Date:  2013-06-27       Impact factor: 22.113

2.  Runx1 promotes murine erythroid progenitor proliferation and inhibits differentiation by preventing Pu.1 downregulation.

Authors:  Michael A Willcockson; Samuel J Taylor; Srikanta Ghosh; Sean E Healton; Justin C Wheat; Tommy J Wilson; Ulrich Steidl; Arthur I Skoultchi
Journal:  Proc Natl Acad Sci U S A       Date:  2019-08-20       Impact factor: 11.205

3.  Differential signaling through p190 and p210 BCR-ABL fusion proteins revealed by interactome and phosphoproteome analysis.

Authors:  J A Cutler; R Tahir; S K Sreenivasamurthy; C Mitchell; S Renuse; R S Nirujogi; A H Patil; M Heydarian; X Wong; X Wu; T-C Huang; M-S Kim; K L Reddy; A Pandey
Journal:  Leukemia       Date:  2017-02-17       Impact factor: 11.528

4.  Genome-wide assessment of recurrent genomic imbalances in canine leukemia identifies evolutionarily conserved regions for subtype differentiation.

Authors:  Sarah C Roode; Daniel Rotroff; Anne C Avery; Steven E Suter; Dorothee Bienzle; Joshua D Schiffman; Alison Motsinger-Reif; Matthew Breen
Journal:  Chromosome Res       Date:  2015-06-03       Impact factor: 5.239

5.  RUNX1a enhances hematopoietic lineage commitment from human embryonic stem cells and inducible pluripotent stem cells.

Authors:  Dan Ran; Wei-Jong Shia; Miao-Chia Lo; Jun-Bao Fan; David A Knorr; Patrick I Ferrell; Zhaohui Ye; Ming Yan; Linzhao Cheng; Dan S Kaufman; Dong-Er Zhang
Journal:  Blood       Date:  2013-01-31       Impact factor: 22.113

6.  Runx1 exon 6-related alternative splicing isoforms differentially regulate hematopoiesis in mice.

Authors:  Yukiko Komeno; Ming Yan; Shinobu Matsuura; Kentson Lam; Miao-Chia Lo; Yi-Jou Huang; Daniel G Tenen; James R Downing; Dong-Er Zhang
Journal:  Blood       Date:  2014-04-25       Impact factor: 22.113

7.  Expression levels of the runt-related transcription factor 1 and 3 genes in the development of acute myeloid leukemia.

Authors:  Adrian Krygier; Dagmara Szmajda; Marta Żebrowska; Agnieszka Jeleń; Ewa Balcerczak
Journal:  Oncol Lett       Date:  2018-03-01       Impact factor: 2.967

8.  Deficiency of the NR4A orphan nuclear receptor NOR1 in hematopoietic stem cells accelerates atherosclerosis.

Authors:  Hua Qing; Yi Liu; Yue Zhao; Jun Aono; Karrie L Jones; Elizabeth B Heywood; Deborah Howatt; Cassi M Binkley; Alan Daugherty; Ying Liang; Dennis Bruemmer
Journal:  Stem Cells       Date:  2014-09       Impact factor: 6.277

9.  Resistance in the Ribosome: RUNX1, pre-LSCs, and HSPCs.

Authors:  Kyoko Ito; Keisuke Ito
Journal:  Cell Stem Cell       Date:  2015-08-06       Impact factor: 24.633

Review 10.  The RUNX family in breast cancer: relationships with estrogen signaling.

Authors:  N-O Chimge; B Frenkel
Journal:  Oncogene       Date:  2012-10-08       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.